These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12067233)

  • 1. Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study.
    Gorio A; Lesma E; Madaschi L; Di Giulio AM
    J Neurochem; 2002 Apr; 81(1):194-202. PubMed ID: 12067233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low doses of glycosaminoglycans and insulin-like growth factor-I on motor neuron disease in wobbler mouse.
    Vergani L; Finco C; Di Giulio AM; Muller EE; Gorio A
    Neurosci Lett; 1997 May; 228(1):41-4. PubMed ID: 9197283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse.
    Vergani L; Losa M; Lesma E; Di Giulio AM; Torsello A; Müller EE; Gorio A
    Neuroscience; 1999; 93(2):565-72. PubMed ID: 10465440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review.
    Di Giulio AM; Germani E; Lesma E; Muller E; Gorio A
    Int J Dev Neurosci; 2000; 18(4-5):339-46. PubMed ID: 10817918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term neuroprotective effects of glycosaminoglycans-IGF-I cotreatment in the motor neuron degeneration (mnd) mutant mouse.
    Gorio A; Germani E; Lesma E; Rossoni G; Muller EE; Di Giulio AM
    Eur J Neurosci; 1999 Oct; 11(10):3395-404. PubMed ID: 10564347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease.
    Hantaï D; Akaaboune M; Lagord C; Murawsky M; Houenou LJ; Festoff BW; Vaught JL; Rieger F; Blondet B
    J Neurol Sci; 1995 May; 129 Suppl():122-6. PubMed ID: 7595602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
    Iwamoto K; Yoshii Y; Ikeda K
    Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):207-12. PubMed ID: 11464954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
    Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
    Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease.
    Gonzalez Deniselle MC; Garay L; Gonzalez S; Guennoun R; Schumacher M; De Nicola AF
    Exp Neurol; 2005 Oct; 195(2):518-23. PubMed ID: 16095593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans treatment increases IGF-I muscle levels and counteracts motor neuron death: A novel nonanticoagulant action.
    Losa M; Vergani L; Lesma E; Rossoni G; Di Giulio AM; Vercelli A; Torsello A; Muller EE; Gorio A
    J Neurosci Res; 1999 Feb; 55(4):496-505. PubMed ID: 10723059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle.
    Payne AM; Zheng Z; Messi ML; Milligan CE; González E; Delbono O
    J Physiol; 2006 Jan; 570(Pt 2):283-94. PubMed ID: 16293644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor has neuroprotective effects on axotomy-induced spinal motoneuron death and wobbler mouse motoneuron disease.
    Ikeda K; Kinoshita M; Iwasaki Y
    Muscle Nerve; 1996 Jun; 19(6):794-5. PubMed ID: 8609937
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cardiotrophin-1 (CT-1) in a mouse motor neuron disease.
    Mitsumoto H; Klinkosz B; Pioro EP; Tsuzaka K; Ishiyama T; O'Leary RM; Pennica D
    Muscle Nerve; 2001 Jun; 24(6):769-77. PubMed ID: 11360260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-588, a novel neuroprotective agent, delays progression of neuromuscular dysfunction in wobbler mouse motoneuron disease.
    Ikeda K; Iwasaki Y; Kinoshita M; Marubuchi S; Ono S
    Brain Res; 2000 Mar; 858(1):84-91. PubMed ID: 10700601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice.
    Dave KR; Prado R; Busto R; Raval AP; Bradley WG; Torbati D; Pérez-Pinzón MA
    Neuroscience; 2003; 120(1):113-20. PubMed ID: 12849745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.
    Møller AV; Jørgensen SP; Chen JW; Larnkjaer A; Ledet T; Flyvbjerg A; Frystyk J
    Eur J Endocrinol; 2006 Aug; 155(2):297-305. PubMed ID: 16868144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection, neuroregeneration, and interaction with insulin-like growth factor-I: novel non-anticoagulant action of glycosaminoglycans.
    Gorio A; Vergani L; Lesma E; Di Giulio AM
    J Neurosci Res; 1998 Mar; 51(5):559-62. PubMed ID: 9511999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease.
    Fumagalli E; Bigini P; Barbera S; De Paola M; Mennini T
    Exp Neurol; 2006 Mar; 198(1):114-28. PubMed ID: 16386734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.